Abstract
Purpose
The aim of this retrospective study was to assess the performance of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography ([18F]-FDG PET-CT) for diagnosing large-vessel vasculitis (LVV) for a subset of patients at increased risk of rheumatic/immune diseases, taking into account concurrent immunosuppressive therapy.
Materials and methods
The study comprised 64 rheumatological referrals with suspected LVV; half of the patients were on immunosuppressive therapy at the time of examination. The final diagnosis of LVV was established in 31 patients. To evaluate vascular uptake, the nuclear medicine physician employed both a semiquantitative method based on standardised uptake value (SUV) determination and a qualitative method based on a visual score from 0 to 3 on the maximum intensity projection (MIP) reformats. Finally, a joint assessment was carried out between the nuclear medicine physician and the reporting radiologist, in which PET metabolic data were re-evaluated taking into account clinical data and baseline CT scans. McNemar’s test was used to compare four types of analysis: semiquantitative (cutoff ≥2.4), qualitative with standard cutoff (grade ≥2), qualitative with reduced cutoff (grade ≥1) and joint.
Results
Semiquantitative analysis (sensitivity 74.19%, specificity 78.78%, accuracy 76.56%) and qualitative analysis with standard cutoff (sensitivity 64.51%, specificity 84.84%, accuracy 75.00%) showed no statistical difference for the diagnosis of LVV, whereas qualitative analysis with lower cutoff (sensitivity 93.54%, specificity 75.75%, accuracy 84.37%) proved to be better than the other two. Joint analysis (sensitivity 93.54%, specificity 93.93%, accuracy 93.75%) introduced some corrective elements not present in the qualitative analysis with cutoff ≥1 and therefore increased specificity significantly.
Conclusions
Interpretation of PET-CT should be individualised for each patient by taking into account clinical-radiological and metabolic data. To this end, cooperation between the nuclear medicine specialist and the radiologist is essential.
Riassunto
Obiettivo
Lo scopo di questo studio retrospettivo è stato di verificare la performance diagnostica della PET-TC con 18F-FDG nella ricerca di vasculite dei grandi vasi (VGV) in un campione di pazienti a elevato sospetto reumatologico, considerando l’influenza della concomitante terapia immunosoppressiva.
Materiali e metodi
Sono stati inclusi 64 pazienti inviati dal reumatologo per sospetta VGV; metà dei pazienti al momento dell’esame erano in terapia immunosoppressiva. La diagnosi finale di VGV è stata stabilita in 31 su 64 pazienti. Per valutare la captazione vascolare il medico nucleare ha utilizzato sia il metodo semi-quantitativo, basato sulla misurazione del SUV, che il metodo qualitativo, assegnando un punteggio visuale da 0 a 3 sulle ricostruzioni MIP. Infine, è stato formulato un giudizio “collegiale” insieme al radiologo, rivalutando i dati metabolici PET alla luce delle informazioni cliniche e delle immagini TC. Quattro tipi di analisi sono state confrontate utilizzando il test di McNemar: semi-quantitativa (cutoff ≥2,4), qualitativa con soglia standard (grado ≥2), qualitativa con soglia inferiore (grado ≥1) e collegiale.
Risultati
L’analisi semiquantitativa (sens 74,19%, spec 78,78%, acc 76,56%) e quella qualitativa con soglia standard (sens 64,51%, spec 84,84%, acc 75,00%) non hanno presentato differenze statisticamente significative nella diagnosi di VGV, mentre il metodo qualitativo con soglia inferiore (sens 93,54%, spec 75,75%, acc 84,37%) è risultato superiore a entrambe. L’analisi collegiale (sens 93,54%, spec 93,93%, acc 93,75%), introducendo alcuni elementi correttivi rispetto al metodo qualitativo con soglia ≥1, ha consentito di aumentare significativamente la specificità.
Conclusioni
L’interpretazione dell’esame PET-TC deve essere individualizzata per il singolo paziente, basandosi sull’integrazione tra i dati clinico-radiologici e l’imaging metabolico: a tale fine è essenziale la collaborazione tra medico nucleare e radiologo.
Similar content being viewed by others
References/Bibliografia
Pelosi E, Skanjeti A, Penna D et al (2011) Role of integrated PET/CT with [(1)F]-FDG in the management of patients with fever of unknown origin: a single-centre experience. Radiol Med 116:809–820, doi: 10.1007/s11547-011-0649-x
Meller J, Sahlmann CO, Scheel AK (2007) 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:35–45
Fries JF, Hunder GG, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33:1135–1136
Bruschi M, De Leonardis F, Govoni M et al (2008) 18FDG-PET and large vessel vasculitis: preliminary data on 25 patients. Reumatismo 60:212–216
Gonzalez-Gay MA, Garcia-Porrua C, Llorca J et al (2001) Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30:249–256, doi: 10.1053/ sarh.2001.16650
Andrews J, Mason JC (2007) Takayasu’s arteritis—recent advances in imaging offer promise. Rheumatology (Oxford) 46:6–15, doi: 10.1093/ rheumatology/kel323
Webb M, Al-Nahhas A (2006) Molecular imaging of Takayasu’s arteritis and other large-vessel vasculitis with 18F-FDG PET. Nucl Med Commun 27:547–549
Zerizer I, Tan K, Khan S et al (2010) Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol 73:504–509, doi: 10.1016/j.ejrad.2010.01.021
Spira D, Kotter I, Ernemann U et al (2010) Imaging of primary and secondary inflammatory diseases involving large and medium-sized vessels and their potential mimics: a multitechnique approach. AJR Am J Roentgenol 194:848–856, doi: 10.2214/ AJR.09.3367
Gornik HL, Creager MA (2008) Aortitis. Circulation 117:3039–3051, doi: 10.1161/ CIRCULATIONAHA.107.760686
Chirinos JA, Tamariz LJ, Lopes G et al (2004) Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol 23:152–159, doi: 10.1007/s10067-003-0816-0
Papathanasiou ND, Du Y, Menezes LJ, Al-Muhaideb A et al (2011) 18F-Fluorodeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol [Epub ahead of print] doi:10.1259/bjr/16422950
Watts RA, Suppiah R, Merkel PA et al (2011) Systemic vasculitis—is it time to reclassify? Rheumatology (Oxford) 50:643–645, doi: 10.1093/rheumatology/keq229
Hautzel H, Sander O, Heinzel A et al (2008) Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 49:1107–1113, doi: 10.2967/ jnumed.108.051920
Kobayashi Y, Ishii K, Oda K et al (2005) Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 46:917–922
Meller J, Strutz F, Siefker U et al (2003) Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30:730–736, doi: 10.1007/s00259-003-1144-y
Walter MA, Melzer RA, Schindler C et al (2005) The value of [18F]FDGPET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32:674–681, doi: 10.1007/s00259-004-1757-9
Belhocine T, Blockmans D, Hustinx R et al (2003) Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 30:1305–1313 doi: 10.1007/ s00259-003-1209-y
Both M, Ahmadi-Simab K, Reuter M et al (2008) MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 67:1030–1033, doi: 10.1136/ard.2007.082123
Pipitone N, Versari A, Salvarani C (2008) Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 47:403–408, doi: 10.1093/ rheumatology/kem379
Tahara N, Kai H, Nakaura H et al (2007) The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J 28:2243–2248, doi: 10.1093/eurheartj/ehm245
Bural GG, Torigian DA, Chamroonrat W et al (2008) FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35:562–569, doi: 10.1007/s00259-007-0528-9
Kuehl H, Eggebrecht H, Boes T et al (2008) Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation. Heart 94:1472–1477, doi: 10.1136/hrt.2007.127282
Tatò F, Hoffmann U (2006) Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg. 44:176–182, doi: 10.1016/j. jvs.2006.02.054
Bertagna F, Bosio G, Caobelli F et al (2010) Role of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography for therapy evaluation of patients with large-vessel vasculitis. Jpn J Radiol 28:199–204, doi: 10.1007/s11604-009-0408-2
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rozzanigo, U., Pellegrin, A., Centonze, M. et al. Diagnosis of large-vessel vasculitis using [18F]-FDG PET-CT. Radiol med 118, 633–647 (2013). https://doi.org/10.1007/s11547-012-0901-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-012-0901-z